已收盘 12-24 16:00:00 美东时间
+0.060
+0.92%
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
12-16 09:36
Citigroup analyst Jason Bazinet maintains Vivid Seats (NASDAQ:SEAT) with a Neutral and lowers the price target from $10 to $8.5.
12-16 05:24
Gainers Arena Group Holdings (AMEX:AREN) shares moved upwards by 11.0% to $5.2...
11-12 20:05
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 10:22
2026 Initial OutlookVivid Seats anticipates Marketplace GOV and Adjusted EBITDA for the year ending December 31, 2026 to be:•Marketplace GOV in the range of $2.2 billion to $2.6 billion•Adjusted EBITDA in the range of
11-06 19:46
Vivid Seats (NASDAQ:SEAT) reported quarterly losses of $(1.91) per share which missed the analyst consensus estimate of $(1.09) by 75.23 percent. This is a 338.75 percent decrease over earnings of $0.80 per share from
11-06 19:41
Vivid Seats Inc. (NASDAQ: SEAT) ("Vivid Seats" or "we"), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events
11-06 19:40
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
CHICAGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ:SEAT) ("Viv...
10-29 04:05